Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]

Clinical trial NCT00094328 · COMPLETED

Trial details

NCT number: NCT00094328
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Puberty, Precocious

Start date: 2004-11-22
Primary completion: 2008-05-22
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.